Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 7 2014
Washington D.C., May 7, 2014 – The Biotechnology Industry Organization (BIO) and ViS Research (ViS) announce the expansion of its Pediatric...
May 7 2014
The Biotechnology Industry Organization (BIO) welcomes the release of the White House National Climate Assessment, because the tools of biotechnology are...
May 6 2014
WASHINGTON, D.C. (May 6, 2014) – Farmers around the world who use seeds improved with biotechnology are benefitting economically while improving the...
May 5 2014
Washington, D.C. (May 5, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO International...
May 5 2014
Consumer interests will be showcased in Plenary Program and Select Track Sessions Washington, D.C. (May 5, 2014) – Nationwide, consumers are...
May 1 2014
Washington, D.C. (April 30, 2014) – Joseph Damond, Senior Vice President of International Affairs for the Biotechnology Industry Organization (BIO),...
Apr 28 2014
BIO President & CEO James Greenwood to moderate panel discussion with biotech companies Washington, D.C. (April 28, 2014) – Recent passage of...
Apr 23 2014
Washington, D.C. (April 23, 2014) – The 2014 BIO International Convention® will include six timely and dynamic Super Sessions featuring prominent...
Apr 21 2014
Emerging companies to showcase their ground-breaking achievements Washington, D.C. (April 21, 2014) – Investment and partnership opportunities are...


Biotechnology News

September 2, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

September 2, 2014

NEW YORK--(BUSINESS WIRE)--David R. Guyer, M.D., CEO of Ophthotech Corp. will present an overview of the Company at the Morgan Stanley Global Healthcare Conference in New...

September 2, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the closing of a $16 million Series B financing to fund continued development of its proprietary...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal...

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman...